April 16th 2024
Teva quantifies generics shortages in new report
Vulnerabilities in the supply chain are increasing the risk of shortages, and restricting the number of therapeutic options available to the patients.
According to data from Teva:
69 per cent of generics marketed in 2022 have fewer than two suppl